secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2025-07-16T23:59:59+00:00
Accession:  0001641172-25-019844
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen granted patents for QN-302 covering 25 countries through 2040
----------------------------------------------------------------------

- Patents for QN-302 granted in over 20 European countries plus India, China, and Russia.
- Patent titled 'Substituted Naphthalene Diimides and Their Use' covers product and manufacturing methods.
- Expiration extends to 2040; drug targets pancreatic and gastrointestinal cancers.
- Qualigen licensed QN-302 from University College of London (Prof. Stephen Neidle).
- CEO states patent coverage strengthens position as drug development company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000164117225019844/0001641172-25-019844-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000164117225019844/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-019844

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer